Literature DB >> 36198833

HSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling.

Hui-Min Cheng1, Mingming Xing1, Ya-Ping Zhou1, Weitao Zhang1, Zeyu Liu1, Lan Li1, Zuguo Zheng1, Yuanchen Ma2, Pingping Li3,4, Xiaoxuan Liu1, Ping Li1, Xiaojun Xu5,6.   

Abstract

Heat shock protein 90β (Hsp90β, encoded by Hsp90ab1 gene) is the most abundant proteins in the cells and contributes to variety of biological processes including metabolism, cell growth and neural functions. However, genetic evidences showing Hsp90β in vivo functions using tissue specific knockout mice are still lacking. Here, we showed that Hsp90β exerted paralogue-specific role in osteoclastogenesis. Using myeloid-specific Hsp90ab1 knockout mice, we provided the first genetic evidence showing the in vivo function of Hsp90β. Hsp90β binds to Ikkβ and reduces its ubiquitylation and proteasomal degradation, thus leading to activated NF-κB signaling. Meanwhile, Hsp90β increases cholesterol biosynthesis by activating Srebp2. Both pathways promote osteoclastogenic genes expression. Genetic deletion of Hsp90ab1 in osteoclast or pharmacological inhibition of Hsp90β alleviates bone loss in ovariectomy-induced mice. Therefore, Hsp90β is a promising druggable target for the treatment of osteoporosis.
© 2022. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Year:  2022        PMID: 36198833     DOI: 10.1038/s41418-022-01071-3

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  51 in total

Review 1.  The IKK NF-kappa B system: a treasure trove for drug development.

Authors:  Michael Karin; Yumi Yamamoto; Q May Wang
Journal:  Nat Rev Drug Discov       Date:  2004-01       Impact factor: 84.694

2.  Stimulation of bone formation in vitro and in rodents by statins.

Authors:  G Mundy; R Garrett; S Harris; J Chan; D Chen; G Rossini; B Boyce; M Zhao; G Gutierrez
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

3.  Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis.

Authors:  John C Clohisy; Yasuhiro Yamanaka; Roberta Faccio; Yousef Abu-Amer
Journal:  J Orthop Res       Date:  2006-07       Impact factor: 3.494

4.  HMG-CoA reductase inhibitors and the risk of fractures.

Authors:  C R Meier; R G Schlienger; M E Kraenzlin; B Schlegel; H Jick
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

5.  Regulation of osteoclast differentiation by statins.

Authors:  W A Grasser; A P Baumann; S F Petras; H J Harwood; R Devalaraja; R Renkiewicz; V Baragi; D D Thompson; V M Paraklar
Journal:  J Musculoskelet Neuronal Interact       Date:  2003-03       Impact factor: 2.041

6.  Involvement of cholesterol in osteoclast-like cell formation via cellular fusion.

Authors:  T Sato; I Morita; S Murota
Journal:  Bone       Date:  1998-08       Impact factor: 4.398

7.  Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins.

Authors:  E Luegmayr; H Glantschnig; G A Wesolowski; M A Gentile; J E Fisher; G A Rodan; A A Reszka
Journal:  Cell Death Differ       Date:  2004-07       Impact factor: 15.828

8.  Osteoporosis: A Review of Treatment Options.

Authors:  Kristie N Tu; Janette D Lie; Chew King Victoria Wan; Madison Cameron; Alaina G Austel; Jenny K Nguyen; Kevin Van; Diana Hyun
Journal:  P T       Date:  2018-02

9.  Coupling of bone resorption and formation by RANKL reverse signalling.

Authors:  Yuki Ikebuchi; Shigeki Aoki; Masashi Honma; Madoka Hayashi; Yasutaka Sugamori; Masud Khan; Yoshiaki Kariya; Genki Kato; Yasuhiko Tabata; Josef M Penninger; Nobuyuki Udagawa; Kazuhiro Aoki; Hiroshi Suzuki
Journal:  Nature       Date:  2018-09-05       Impact factor: 49.962

Review 10.  Mechanisms of bone anabolism regulated by statins.

Authors:  Feng Ruan; Qiang Zheng; Jinfu Wang
Journal:  Biosci Rep       Date:  2012-12       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.